Alpine Immune Sciences Inc (NASDAQ:ALPN)
| 11.84 Delayed Data As of May 11 |  -0.61 / -4.90%Today’s Change | 2.58 Today|||52-Week Range 16.37 | -6.03% Year-to-Date |
Latest ALPN News | Press Releases
| Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline May 06 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 12.45 |
| Today’s open | 12.00 |
| Day’s range | 11.84 - 12.25 |
| Volume | 6,989 |
| Average volume (3 months) | 113,930 |
| Market cap | $284.9M |
Data as of 3:59pm ET, 05/11/2021
Growth & Valuation
| Earnings growth (last year) | +41.15% |
| Earnings growth (this year) | +3.98% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +436.49% |
| P/E ratio | NM |
| Price/Sales | 28.11 |
| Price/Book | 4.56 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| WVEWAVE Life Sciences L... | -0.21 | -3.57% |
| COGTCogent Biosciences I... | -0.05 | -0.64% |
| CRMDCorMedix Inc | +0.07 | +0.86% |
| SYRSSyros Pharmaceutical... | +0.19 | +3.79% |
Data as of 3:59pm ET, 05/11/2021
Financials
| Next reporting date | May 19, 2021 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $9.3M |
| Annual profit (last year) | -$27.9M |
| Net profit margin | -299.30% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
